Low Dose Oral Minoxidil in Androgenetic Alopecia

The study conducted at Jinnah Postgraduate Medical Centre in Karachi assessed the effectiveness of low-dose oral minoxidil (LDOM) for androgenetic alopecia (AGA) in 76 participants, comparing 2.5 mg and 1 mg doses. Both doses improved hair growth, but the 2.5 mg dose was significantly more effective in increasing hair count, density, and diameter. Adverse effects were minor and well-tolerated. The study concluded that the 2.5 mg dose is a more effective treatment option for AGA, though further research is needed to establish optimal dosing and long-term safety.